RGCB scientists uncover new mechanism behind malaria parasite’s drug resistance
Researchers at the RGCB have discovered that young red blood cells provide a protective environment for malaria parasites, helping them resist artemisinin treatment. This finding shifts the focus of drug resistance from purely genetic parasite mutations to the role of host cell biology.
Why it matters
Understanding this mechanism could lead to more effective malaria treatments for vulnerable populations like children and anaemic patients who have higher levels of these protective blood cells.
In a major scientific breakthrough, researchers at the BRIC-RGCB here have discovered a previously unknown mechanism by which malaria parasites evade the effects of artemisinin, the world’s most widely used antimalarial drug.
The article reports on scientific findings from a research institution without political or ideological framing.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in